Johanna Weiß

5.5k total citations
167 papers, 4.4k citations indexed

About

Johanna Weiß is a scholar working on Oncology, Pharmacology and Molecular Biology. According to data from OpenAlex, Johanna Weiß has authored 167 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 90 papers in Oncology, 51 papers in Pharmacology and 45 papers in Molecular Biology. Recurrent topics in Johanna Weiß's work include Drug Transport and Resistance Mechanisms (87 papers), Pharmacogenetics and Drug Metabolism (46 papers) and Pharmacological Effects and Toxicity Studies (40 papers). Johanna Weiß is often cited by papers focused on Drug Transport and Resistance Mechanisms (87 papers), Pharmacogenetics and Drug Metabolism (46 papers) and Pharmacological Effects and Toxicity Studies (40 papers). Johanna Weiß collaborates with scholars based in Germany, United States and Argentina. Johanna Weiß's co-authors include Walter E. Haefeli, Dirk Theile, Gerd Mikus, Jürgen Burhenne, Heike Lindenmaier, Nahal Ketabi‐Kiyanvash, Caroline Henrike Storch, Klaus‐Dieter Riedel, Michael M. Hoffmann and I. Walter‐Sack and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and Analytical Biochemistry.

In The Last Decade

Johanna Weiß

165 papers receiving 4.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Johanna Weiß Germany	34	1.8k	1.1k	1.1k	932	807	167	4.4k
Werner Siegmund Germany	42	2.7k 1.5×	556 0.5×	1.1k 1.0×	1.5k 1.7×	1.0k 1.3×	185	6.3k
In‐Jin Jang South Korea	40	1.6k 0.9×	693 0.6×	1.5k 1.4×	777 0.8×	1.2k 1.5×	306	5.9k
Noboru Okamura Japan	32	1.4k 0.8×	452 0.4×	1.0k 1.0×	780 0.8×	451 0.6×	142	3.8k
Bruno Lacarelle France	35	1.2k 0.7×	738 0.7×	951 0.9×	364 0.4×	508 0.6×	169	3.7k
Stefan Oswald Germany	35	2.0k 1.1×	344 0.3×	687 0.6×	947 1.0×	955 1.2×	117	3.8k
Oliver von Richter Germany	25	2.9k 1.6×	492 0.5×	973 0.9×	1.8k 1.9×	1.5k 1.9×	66	4.6k
Ashim K. Mitra United States	41	1.2k 0.7×	579 0.5×	1.5k 1.4×	573 0.6×	379 0.5×	144	4.6k
Xiaoyan Chu United States	40	3.2k 1.8×	460 0.4×	1.2k 1.1×	1.8k 1.9×	1.7k 2.1×	90	5.0k
Katsuhiko Okumura Japan	39	2.3k 1.3×	603 0.6×	1.4k 1.3×	1.3k 1.4×	874 1.1×	179	5.2k
Rory P. Remmel United States	45	894 0.5×	791 0.7×	1.2k 1.1×	1.4k 1.5×	965 1.2×	148	5.5k

Countries citing papers authored by Johanna Weiß

Since Specialization

Citations

This map shows the geographic impact of Johanna Weiß's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johanna Weiß with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johanna Weiß more than expected).

Fields of papers citing papers by Johanna Weiß

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Johanna Weiß. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johanna Weiß. The network helps show where Johanna Weiß may publish in the future.

Co-authorship network of co-authors of Johanna Weiß

This figure shows the co-authorship network connecting the top 25 collaborators of Johanna Weiß. A scholar is included among the top collaborators of Johanna Weiß based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Johanna Weiß. Johanna Weiß is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Köberle, Beate, Sebastian Honnen, Jürgen Burhenne, et al.. (2024). RNA is a pro-apoptotic target of cisplatin in cancer cell lines and C. elegans. Biomedicine & Pharmacotherapy. 173. 116450–116450. 1 indexed citations

Sauter, Max, Andreas D. Meid, Jürgen Burhenne, et al.. (2024). Effect of Tacrolimus Formulation (Prolonged‐Release vs Immediate‐Release) on Its Susceptibility to Drug‐Drug Interactions with St. John's Wort. Clinical Pharmacology in Drug Development. 13(3). 297–306. 2 indexed citations

Meid, Andreas D., et al.. (2024). Coadministration of fluconazole to boost subtherapeutic sirolimus concentrations: A case report. Pharmacology Research & Perspectives. 12(3). e1198–e1198. 1 indexed citations

Burhenne, Jürgen, et al.. (2024). A Highly Sensitive UPLC-MS/MS Method for the Quantification of the Organic Cation Transporters’ Mediated Metformin Uptake and Its Inhibition in Cells. Molecules. 29(21). 5162–5162. 1 indexed citations

Burhenne, Jürgen, Johanna Weiß, Mathias Haag, et al.. (2023). Evaluation of the drug-drug interaction potential of the novel hepatitis B and D virus entry inhibitor bulevirtide at OATP1B in healthy volunteers. Frontiers in Pharmacology. 14. 1128547–1128547. 4 indexed citations

Haefeli, Walter E., et al.. (2022). Functional Characterization of the Solute Carrier LAT-1 (SLC7A5/SLC3A2) in Human Brain Capillary Endothelial Cells with Rapid UPLC-MS/MS Quantification of Intracellular Isotopically Labelled L-Leucine. International Journal of Molecular Sciences. 23(7). 3637–3637. 10 indexed citations

Benzel, Julia, Philipp Uhl, Abigail Davis, et al.. (2021). Investigating the Central Nervous System Disposition of Actinomycin D: Implementation and Evaluation of Cerebral Microdialysis and Brain Tissue Measurements Supported by UPLC-MS/MS Quantification. Pharmaceutics. 13(9). 1498–1498. 3 indexed citations

Theile, Dirk, et al.. (2021). Time-Resolved Effect of Interferon-Alpha 2a on Activities of Nuclear Factor Kappa B, Pregnane X Receptor and on Drug Disposition Genes. Pharmaceutics. 13(6). 808–808. 4 indexed citations

Longuespée, Rémi, Dirk Theile, Margaux Fresnais, et al.. (2020). Approaching sites of action of drugs in clinical pharmacology: New analytical options and their challenges. British Journal of Clinical Pharmacology. 87(3). 858–874. 13 indexed citations

10.

Weiß, Johanna, Giuseppe Gattuso, Davide Barreca, & Walter E. Haefeli. (2020). Nobiletin, sinensetin, and tangeretin are the main perpetrators in clementines provoking food-drug interactions in vitro. Food Chemistry. 319. 126578–126578. 26 indexed citations

11.

Weiß, Johanna, et al.. (2020). Potential Risk of Food-Drug Interactions: Citrus Polymethoxyflavones and Flavanones as Inhibitors of the Organic Anion Transporting Polypeptides (OATP) 1B1, 1B3, and 2B1. European Journal of Drug Metabolism and Pharmacokinetics. 45(6). 809–815. 10 indexed citations

12.

Lehmann, Marie‐Louise, Kathrin I. Foerster, Jürgen Burhenne, et al.. (2019). Perpetrator effects of ciclosporin (P‐glycoprotein inhibitor) and its combination with fluconazole (CYP3A inhibitor) on the pharmacokinetics of rivaroxaban in healthy volunteers. British Journal of Clinical Pharmacology. 85(7). 1528–1537. 24 indexed citations

13.

Hohmann, Nicolas, Antje Blank, Johanna Weiß, et al.. (2017). Autoinhibitory properties of the parent but not of the N‐oxide metabolite contribute to infusion rate‐dependent voriconazole pharmacokinetics. British Journal of Clinical Pharmacology. 83(9). 1954–1965. 19 indexed citations

14.

Theile, Dirk, Rolf Warta, Juan Pablo Rigalli, et al.. (2014). Antiproliferative efficacies but minor drug transporter inducing effects of paclitaxel, cisplatin, or 5-fluorouracil in a murine xenograft model for head and neck squamous cell carcinoma. Cancer Biology & Therapy. 15(4). 436–442. 8 indexed citations

15.

Weiß, Johanna, Sybille Baumann, Dirk Theile, & Walter E. Haefeli. (2014). Desmethyl bosentan displays a similar in vitro interaction profile as bosentan. Pulmonary Pharmacology & Therapeutics. 30. 80–86. 3 indexed citations

16.

Riedel, Klaus‐Dieter, et al.. (2012). In vitro identification of the cytochrome P450 isozymes involved in the N-demethylation of the active opioid metabolite nortilidine to bisnortilidine. Naunyn-Schmiedeberg s Archives of Pharmacology. 385(6). 633–639. 9 indexed citations

17.

Theile, Dirk, Nahal Ketabi‐Kiyanvash, Christel Herold‐Mende, et al.. (2010). Evaluation of drug transporters' significance for multidrug resistance in head and neck squamous cell carcinoma. Head & Neck. 33(7). 959–968. 26 indexed citations

18.

Burhenne, Jürgen, Claudia Röder, T. Heinrich, et al.. (2010). No Evidence for Induction of ABC Transporters in Peripheral Blood Mononuclear Cells in Humans after 14 Days of Efavirenz Treatment. Antimicrobial Agents and Chemotherapy. 54(10). 4185–4191. 24 indexed citations

19.

Weiß, Johanna, Dirk Theile, Nahal Ketabi‐Kiyanvash, Heike Lindenmaier, & Walter E. Haefeli. (2006). Inhibition of MRP1/ABCC1, MRP2/ABCC2, and MRP3/ABCC3 by Nucleoside, Nucleotide, and Non-Nucleoside Reverse Transcriptase Inhibitors. Drug Metabolism and Disposition. 35(3). 340–344. 108 indexed citations

20.

Weiß, Johanna, Walter E. Haefeli, Christiane Gasse, et al.. (2003). Lack of Evidence for Association of High Altitude Pulmonary Edema and Polymorphisms of the NO Pathway. High Altitude Medicine & Biology. 4(3). 355–366. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact